Search

Your search keyword '"Renauer, Paul A."' showing total 151 results

Search Constraints

Start Over You searched for: Author "Renauer, Paul A." Remove constraint Author: "Renauer, Paul A."
151 results on '"Renauer, Paul A."'

Search Results

10. Data from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function

11. Supplementary Table S1 from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function

12. Supplementary Figures from Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function

14. Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function

16. Supplementary NGS Datasets from CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

17. Supplementary Tables from CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

18. Data from CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

19. Supplementary Data from CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

20. CTLA-4 tail fusion enhances CAR-T anti-tumor immunity

21. Perturbomics of tumor-infiltrating NK cells

22. Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function

25. Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species

27. Simultaneous and sequential multi-species coronavirus vaccination

28. Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2

30. Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

33. Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

34. CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade

35. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells

36. Convergent Identification and Interrogation of Tumor-Intrinsic Factors that Modulate Cancer Immunity In Vivo

38. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma

40. GG-01 Hypomethylation of STAT1 and HLA-DRB1 in CD8+ T cells is associated with type-I interferon-dependent HLA-DRB1 overexpression and activation of autologous CD4+ T cells in systemic lupus erythematosus

42. CD4+CD28+KIR+CD11ahi T cells correlate with disease activity and are characterized by a pro-inflammatory epigenetic and transcriptional profile in lupus patients

43. Dense Genotyping of Immune Related Loci in a Multi-Ethnic Behcet's Disease Cohort Identifies Genetic Associations in a Long Noncoding RNA Near QSOX2, RASIP1/FUT2, and IL12A-AS1

44. Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target

45. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma

46. Directin vivomapping of functional suppressors in glioblastoma genome

47. Genome-wide association study identifies susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in Takayasu’s arteritis

48. Hypomethylation of and is associated with type-I interferon-dependent expression in lupus CD8+ T cells.

50. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus

Catalog

Books, media, physical & digital resources